- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 487/14 - Ortho-condensed systems
Patent holdings for IPC class C07D 487/14
Total number of patents in this class: 1664
10-year publication summary
|
97
|
86
|
97
|
104
|
110
|
109
|
127
|
132
|
108
|
87
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Abbvie Inc. | 1814 |
72 |
| Intra-Cellular Therapies, Inc. | 419 |
43 |
| Pharmacosmos Holding A/S | 201 |
39 |
| Pharmacosmos A/S | 65 |
38 |
| Merck Patent GmbH | 5755 |
36 |
| Novartis AG | 10626 |
30 |
| Agenebio, Inc. | 47 |
28 |
| Idemitsu Kosan Co., Ltd. | 4225 |
26 |
| Achillion Pharmaceuticals, Inc. | 164 |
23 |
| Dana-Farber Cancer Institute, Inc. | 2621 |
21 |
| Genentech, Inc. | 4008 |
20 |
| Prelude Therapeutics, Incorporated | 140 |
19 |
| Bristol-myers Squibb Company | 4824 |
18 |
| Bayer Pharma AG | 1049 |
18 |
| Samsung Display Co., Ltd. | 36165 |
16 |
| Duk San Neolux Co., Ltd. | 666 |
16 |
| Incyte Corporation | 1035 |
15 |
| Bayer AG | 3388 |
14 |
| The Board of Trustees of the Leland Stanford Junior University | 6526 |
14 |
| G1 Therapeutics, Inc. | 40 |
14 |
| Other owners | 1144 |